1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account

GNR to donate proceeds from Clotamin sales to The National Alliance for Thrombosis and Thrombosis

Global Nutritional Research, the manufactures of Clotamin, today announced that proceeds from every bottle sold will go to support The National Alliance for Thrombosis and Thrombophilia.

FOR IMMEDIATE RELEASE

 
Clotamin
Clotamin
PRLog (Press Release) - Jul 09, 2009 -
Kensington, MD - Global Nutritional Research, the manufactures of Clotamin, today announced that proceeds from every bottle sold will go to support The National Alliance for Thrombosis and Thrombophilia. The National Alliance for Thrombosis and Thrombophilia (NATT) is a patient-led advocacy organization providing patient education and professional training on the signs, symptoms and prevention of blood clots and clotting disorders. NATT combines the unique perspectives of health care providers, individuals afflicted with clotting disorders and community leaders who are passionate about this health care crisis. NATT's Medical and Scientific Advisory Board includes nationally recognized experts on thrombosis and thrombophilia.

NATT President Randy Fenninger said "I want to thank Clotamin for its commitment to support NATT." Fenninger added that "I look forward to working with Clotamin to advance education and outreach programs to individuals with clotting disorders."

NATT is working closely with the Centers for Disease Control and Prevention (CDC), hemophilia and thrombophilia treatment centers and anticoagulation clinics. Stop-the-Clot™ Education Project.

"We couldn't be more excited about being able to support NATT. My brother and I have been deeply affected by blood clots and we hope our support of NATT will help get to get the message out about Thrombosis and Thrombophilia," says Justin Barch, founder of GNR.

Clotamin is a complete multivitamin specially formulated without vitamin k for the nutritional needs of people taking blood thinning medications (anticoagulants). Clotamin can be taken with blood thinning medication warfarin (also known under the brand names of Coumadin™, Jantoven™, Marevan™, and Waran™) without affecting international normalized ratio (INR) levels. Unlike most multivitamins on the market, Clotamin contains no vitamin k which can thicken blood and interfere with warfarin treatment. For more information about Global Nutritional Research and Clotamin please visit http://www.clotamin.com.

About NATT (The National Alliance for Thrombosis and Thrombophilia)

The National Alliance for Thrombosis and Thrombophilia is a patient-led advocacy organization providing patient education and professional training on the signs, symptoms and prevention of blood clots and clotting disorders. NATT combines the unique perspectives of health care providers, individuals afflicted with clotting disorders and community leaders who are passionate about this health care crisis. NATT's Medical and Scientific Advisory Board includes nationally recognized experts on thrombosis and thrombophilia. For more information about NATT please visit http://www.stoptheclot.org.

# # #

Global Nutritional Research is the manufacturer of Clotamin (http://www.clotamin.com) is a once a day multivitamin without vitamin k for people on blood thinners. Clotamin can be taken with the blood thinning medication Warfarin without affecting INR levels.

--- end ---

Click to Share

Contact Email:
***@clotamin.com Email Verified
Issued By:Global Nutritional Research
Phone:866.650.2568
Fax:1240-235-3827
Address:PO Box 182
:Kensington, MD 20895-0182
Zip:20895
City/Town:Kensington
State/Province:Maryland
Country:United States
Industry:Health, Medical
Tags:clotamin, , , natt, national alliance for thrombosis and thrombophilia, , clotting disorders
Last Updated:Jul 10, 2009
Shortcut:http://prlog.org/10278320
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share